CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: propane
Accession: CHEBI:32879
browse the term
Definition: An alkane that has formula C3H8.
Synonyms: related_synonym: CH3-CH2-CH3; E944; Formula=C3H8; InChI=1S/C3H8/c1-3-2/h3H2,1-2H3; InChIKey=ATUOYWHBWRKTHZ-UHFFFAOYSA-N; Propan; SMILES=CCC
xref: Beilstein:1730718; CAS:74-98-6; Gmelin:25044
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
increases expression
EXP
1-nitropropane results in increased expression of ABCB1B mRNA
CTD
PMID:17070881
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
G
Acmsd
aminocarboxymuconate semialdehyde decarboxylase
increases expression
EXP
1-nitropropane results in increased expression of ACMSD mRNA
CTD
PMID:17070881
NCBI chr13:44,424,689...44,468,734
Ensembl chr13:44,424,689...44,468,734
G
Acsl3
acyl-CoA synthetase long-chain family member 3
decreases expression
EXP
1-nitropropane results in decreased expression of ACSL3 mRNA
CTD
PMID:17070881
NCBI chr 9:84,569,601...84,593,565
Ensembl chr 9:84,569,597...84,593,565
G
Aen
apoptosis enhancing nuclease
increases expression
EXP
1-nitropropane results in increased expression of AEN mRNA
CTD
PMID:17070881
NCBI chr 1:140,584,328...140,593,749
Ensembl chr 1:140,584,380...140,593,745
G
Akr7a3
aldo-keto reductase family 7 member A3
decreases expression
EXP
1-nitropropane results in decreased expression of AKR7A3 mRNA
CTD
PMID:17070881
NCBI chr 5:157,801,120...157,813,756
Ensembl chr 5:157,801,163...157,813,756
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
EXP
1-nitropropane results in increased expression of ALDH1A1 mRNA
CTD
PMID:17070881
NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
G
Aldh1a7
aldehyde dehydrogenase family 1, subfamily A7
increases expression
EXP
1-nitropropane results in increased expression of ALDH1A4 mRNA
CTD
PMID:17070881
NCBI chr 1:240,584,233...240,601,843
Ensembl chr 1:240,562,423...240,601,744
G
Apoa2
apolipoprotein A2
increases expression
EXP
1-nitropropane results in increased expression of APOA2 mRNA
CTD
PMID:17070881
NCBI chr13:89,596,872...89,598,805
Ensembl chr13:89,597,138...89,598,802
G
Apoa4
apolipoprotein A4
decreases expression
EXP
1-nitropropane results in decreased expression of APOA4 mRNA
CTD
PMID:17070881
NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
G
Apoc3
apolipoprotein C3
increases expression
EXP
1-nitropropane results in increased expression of APOC3 mRNA
CTD
PMID:17070881
NCBI chr 8:50,529,318...50,531,498
Ensembl chr 8:50,529,318...50,531,498
G
Atp6v1d
ATPase H+ transporting V1 subunit D
increases expression
EXP
1-nitropropane results in increased expression of ATP6V1D mRNA
CTD
PMID:17070881
NCBI chr 6:102,032,271...102,047,754
Ensembl chr 6:102,032,276...102,047,758
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
1-nitropropane results in increased expression of BAX mRNA
CTD
PMID:17070881
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Btg2
BTG anti-proliferation factor 2
decreases expression
EXP
1-nitropropane results in decreased expression of BTG2 mRNA
CTD
PMID:17070881
NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
G
C7
complement C7
decreases expression
EXP
1-nitropropane results in decreased expression of C7 mRNA
CTD
PMID:17070881
NCBI chr 2:54,707,621...54,781,624
Ensembl chr 2:54,709,138...54,777,729
G
Cblc
Cbl proto-oncogene C
decreases expression
EXP
1-nitropropane results in decreased expression of CBLC mRNA
CTD
PMID:17070881
NCBI chr 1:80,699,321...80,716,146
Ensembl chr 1:80,699,323...80,716,146
G
Ccng1
cyclin G1
increases expression
EXP
1-nitropropane results in increased expression of CCNG1 mRNA
CTD
PMID:17070881
NCBI chr10:25,903,925...25,910,298
Ensembl chr10:25,903,911...25,910,325
G
Cd276
Cd276 molecule
decreases expression
EXP
1-nitropropane results in decreased expression of CD276 mRNA
CTD
PMID:17070881
NCBI chr 8:63,312,060...63,350,411
Ensembl chr 8:63,318,019...63,350,269
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
EXP
1-nitropropane results in decreased expression of CDKN1A mRNA
CTD
PMID:17070881
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
G
Cpq
carboxypeptidase Q
decreases expression
EXP
1-nitropropane results in decreased expression of CPQ mRNA
CTD
PMID:17070881
NCBI chr 7:71,709,174...72,167,413
Ensembl chr 7:71,709,157...72,167,417
G
Cryab
crystallin, alpha B
decreases expression
EXP
1-nitropropane results in decreased expression of CRYAB mRNA
CTD
PMID:17070881
NCBI chr 8:55,178,543...55,182,546
Ensembl chr 8:55,178,289...55,182,545
G
Cyp2c13
cytochrome P450, family 2, subfamily c, polypeptide 13
decreases expression
EXP
1-nitropropane results in decreased expression of CYP2C13 mRNA
CTD
PMID:17070881
NCBI chr 1:258,796,624...258,877,023
Ensembl chr 1:258,796,622...258,877,045
G
Cyp4f5
cytochrome P450, family 4, subfamily f, polypeptide 5
increases expression
EXP
1-nitropropane results in increased expression of CYP4F5 mRNA
CTD
PMID:17070881
NCBI chr 7:14,559,806...14,574,345
Ensembl chr 7:14,529,482...14,574,361
G
Ddah1
dimethylarginine dimethylaminohydrolase 1
decreases expression
EXP
1-nitropropane results in decreased expression of DDAH1 mRNA
CTD
PMID:17070881
NCBI chr 2:251,634,368...251,766,009
Ensembl chr 2:251,634,431...251,766,014
G
Epcam
epithelial cell adhesion molecule
decreases expression
EXP
1-nitropropane results in decreased expression of EPCAM mRNA
CTD
PMID:17070881
NCBI chr 6:11,282,194...11,308,870
Ensembl chr 6:11,281,964...11,298,216
G
Ephx1
epoxide hydrolase 1
decreases expression
EXP
1-nitropropane results in decreased expression of EPHX1 mRNA
CTD
PMID:17070881
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
G
Fas
Fas cell surface death receptor
increases expression
EXP
1-nitropropane results in increased expression of FAS mRNA
CTD
PMID:17070881
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Fhit
fragile histidine triad diadenosine triphosphatase
increases expression
EXP
1-nitropropane results in increased expression of FHIT mRNA
CTD
PMID:17070881
NCBI chr15:15,697,292...16,862,873
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
decreases expression
EXP
1-nitropropane results in decreased expression of GRIA3 mRNA
CTD
PMID:17070881
NCBI chr X:127,561,843...127,829,763
Ensembl chr X:127,562,660...127,829,753
G
Gstm1
glutathione S-transferase mu 1
decreases expression
EXP
1-nitropropane results in decreased expression of GSTM1 mRNA
CTD
PMID:17070881
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
G
Hsd17b6
hydroxysteroid (17-beta) dehydrogenase 6
increases expression
EXP
1-nitropropane results in increased expression of HSD17B6 mRNA
CTD
PMID:17070881
NCBI chr 7:2,412,370...2,431,249
Ensembl chr 7:2,412,363...2,431,197 Ensembl chr13:2,412,363...2,431,197
G
Il2ra
interleukin 2 receptor subunit alpha
decreases expression
EXP
1-nitropropane results in decreased expression of IL2RA mRNA
CTD
PMID:17070881
NCBI chr17:70,500,672...70,547,929
Ensembl chr17:70,499,083...70,548,071
G
Mgmt
O-6-methylguanine-DNA methyltransferase
increases expression
EXP
1-nitropropane results in increased expression of MGMT mRNA
CTD
PMID:17070881
NCBI chr 1:209,237,255...209,464,189
Ensembl chr 1:209,237,233...209,464,190
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
EXP
1-nitropropane results in increased expression of NUPR1 mRNA
CTD
PMID:17070881
NCBI chr 1:194,767,484...194,769,519
Ensembl chr 1:194,767,474...194,769,524
G
Olr37
olfactory receptor 37
increases expression
EXP
1-nitropropane results in increased expression of OLR37 mRNA
CTD
PMID:17070881
NCBI chr 1:164,755,094...164,756,059
G
Phlda3
pleckstrin homology-like domain, family A, member 3
decreases expression
EXP
1-nitropropane results in decreased expression of PHLDA3 mRNA
CTD
PMID:17070881
NCBI chr13:52,588,917...52,592,002
Ensembl chr13:52,588,917...52,592,001
G
Rhobtb2
Rho-related BTB domain containing 2
increases expression
EXP
1-nitropropane results in increased expression of RHOBTB2 mRNA
CTD
PMID:17070881
NCBI chr15:51,465,148...51,485,562
Ensembl chr15:51,465,148...51,485,692
G
Serpina7
serpin family A member 7
decreases expression
EXP
1-nitropropane results in decreased expression of SERPINA7 mRNA
CTD
PMID:17070881
NCBI chr X:110,226,565...110,232,202
Ensembl chr X:110,226,572...110,232,179
G
Slc16a10
solute carrier family 16 member 10
increases expression
EXP
1-nitropropane results in increased expression of SLC16A10 mRNA
CTD
PMID:17070881
NCBI chr20:45,138,433...45,260,155
Ensembl chr20:45,143,453...45,260,119
G
Spink1
serine peptidase inhibitor, Kazal type 1
increases expression
EXP
1-nitropropane results in increased expression of SPINK1 mRNA
CTD
PMID:17070881
NCBI chr18:38,221,919...38,242,092
Ensembl chr18:38,221,681...38,242,119
G
Sugct
succinylCoA:glutarate-CoA transferase
decreases expression
EXP
1-nitropropane results in decreased expression of SUGCT mRNA
CTD
PMID:17070881
NCBI chr17:49,991,314...51,030,950
G
Sulf2
sulfatase 2
increases expression
EXP
1-nitropropane results in increased expression of SULF2 mRNA
CTD
PMID:17070881
NCBI chr 3:162,791,349...162,872,984
Ensembl chr 3:162,791,355...162,872,831
G
Sult2a1
sulfotransferase family 2A member 1
increases expression
EXP
1-nitropropane results in increased expression of SULT2A1 mRNA
CTD
PMID:17070881
NCBI chr 1:76,558,721...76,614,315
Ensembl chr 1:76,252,329...76,780,230
G
Zmat3
zinc finger, matrin type 3
decreases expression
EXP
1-nitropropane results in decreased expression of ZMAT3 mRNA
CTD
PMID:17070881
NCBI chr 2:118,715,229...118,746,109
Ensembl chr 2:118,721,334...118,745,766
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
fluvalinate analog promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]
CTD
PMID:25684042
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
G
Cdk2
cyclin dependent kinase 2
affects binding
ISO
fluvalinate binds to CDK2 protein
CTD
PMID:32278787
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
affects binding
ISO
fluvalinate binds to CYP3A4 protein
CTD
PMID:32278787
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Erbb2
erb-b2 receptor tyrosine kinase 2
affects binding
ISO
fluvalinate binds to ERBB2 protein
CTD
PMID:32278787
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
G
Fgfr2
fibroblast growth factor receptor 2
affects binding
ISO
fluvalinate binds to FGFR2 protein
CTD
PMID:32278787
NCBI chr 1:200,590,951...200,696,946
Ensembl chr 1:200,590,953...200,696,928
G
Mmp9
matrix metallopeptidase 9
affects binding
ISO
fluvalinate binds to MMP9 protein
CTD
PMID:32278787
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Nqo1
NAD(P)H quinone dehydrogenase 1
affects binding
ISO
fluvalinate binds to NQO1 protein
CTD
PMID:32278787
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
fluvalinate inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
CTD
PMID:25257666
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
fluvalinate binds to and results in increased activity of NR1I2 protein
CTD
PMID:21115097
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
G
Ppard
peroxisome proliferator-activated receptor delta
affects binding
ISO
fluvalinate binds to PPARD protein
CTD
PMID:32278787
NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
G
Rora
RAR-related orphan receptor A
affects binding
ISO
fluvalinate binds to RORA protein
CTD
PMID:32278787
NCBI chr 8:75,515,886...75,616,477
Ensembl chr 8:75,516,904...75,607,212
G
Rorc
RAR-related orphan receptor C
affects binding
ISO
fluvalinate binds to RORC protein
CTD
PMID:32278787
NCBI chr 2:195,612,471...195,636,797
Ensembl chr 2:195,617,021...195,637,630
G
Klrc1
killer cell lectin like receptor C1
decreases expression
ISO
ledipasvir co-treated with sofosbuvir decreases expression of NCR1 protein in natural killer cells
RGD
PMID:31218578
RGD:40400920
NCBI chr 4:163,453,435...163,463,718
Ensembl chr 4:163,458,528...163,463,718
G
Ncr1
natural cytotoxicity triggering receptor 1
affects expression
ISO
ledipasvir co-treated sofosbuvir with affects expression of NCR1 protein in natural killer cells
RGD
PMID:31218578
RGD:40400920
NCBI chr 1:73,178,917...73,226,504
Ensembl chr 1:73,179,013...73,226,777
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity multiple interactions
ISO
Ritonavir results in decreased activity of ABCB11 protein Ritonavir inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD
PMID:20829430 PMID:22646477 PMID:23956101 PMID:24014644 PMID:28437613
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
hyperforin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; hypericin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; kaempferol inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]
CTD
PMID:15266218
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
G
Abcb4
ATP binding cassette subfamily B member 4
decreases expression decreases activity
ISO
Ritonavir results in decreased expression of ABCB4 Ritonavir results in decreased activity of ABCB4 protein
CTD
PMID:26626330 PMID:28437613
NCBI chr 4:22,133,984...22,192,687
Ensembl chr 4:22,133,521...22,425,515
G
Acss2
acyl-CoA synthetase short-chain family member 2
affects expression
EXP
Ritonavir affects the expression of ACSS2 mRNA
CTD
PMID:17719200
NCBI chr 3:151,032,925...151,075,856
Ensembl chr 3:151,032,952...151,075,856
G
Adipoq
adiponectin, C1Q and collagen domain containing
decreases expression multiple interactions
ISO
Ritonavir results in decreased expression of ADIPOQ mRNA; Ritonavir results in decreased expression of ADIPOQ protein rosiglitazone inhibits the reaction [Ritonavir results in decreased secretion of ADIPOQ protein] diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of ADIPOQ protein]
CTD
PMID:15865214 PMID:17668557
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
G
Alb
albumin
affects binding
ISO
Ritonavir binds to ALB protein
CTD
PMID:15814459 PMID:16336266
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
G
Bak1
BCL2-antagonist/killer 1
increases expression
ISO
Ritonavir results in increased expression of BAK1 protein
CTD
PMID:19386116
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Ritonavir results in decreased expression of BCL2 protein
CTD
PMID:19386116
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
Ritonavir results in decreased expression of BCL2L1 mRNA
CTD
PMID:16174765
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
Ritonavir results in decreased expression of BIRC5 mRNA; Ritonavir results in decreased expression of BIRC5 protein
CTD
PMID:16174765 PMID:21270666
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Casp1
caspase 1
decreases expression
ISO
Ritonavir results in decreased expression of CASP1 protein
CTD
PMID:10551732
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
G
Casp3
caspase 3
decreases activity
ISO
Ritonavir results in decreased activity of CASP3 protein
CTD
PMID:10551732
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases expression increases secretion decreases expression
ISO
diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of CCL2 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased secretion of CCL2 protein] Ritonavir results in decreased expression of CCL2
CTD
PMID:17668557 PMID:20884875 PMID:26626330
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccl20
C-C motif chemokine ligand 20
decreases expression
ISO
Ritonavir results in decreased expression of CCL20
CTD
PMID:26626330
NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
G
Ccl3
C-C motif chemokine ligand 3
decreases expression increases expression
ISO
Ritonavir results in decreased expression of CCL3 Ritonavir results in increased expression of CCL3 protein
CTD
PMID:17668557 PMID:26626330
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
ISO
Ritonavir results in decreased expression of CCL4
CTD
PMID:26626330
NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
G
Ccna2
cyclin A2
decreases expression
ISO
Ritonavir results in decreased expression of CCNA2 mRNA
CTD
PMID:19386116
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
G
Ccnb1
cyclin B1
decreases expression
ISO
Ritonavir results in decreased expression of CCNB1 mRNA
CTD
PMID:19386116
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
G
Ccnd1
cyclin D1
decreases expression
ISO
Ritonavir results in decreased expression of CCND1 protein
CTD
PMID:16551874 PMID:21270666
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Ccnd2
cyclin D2
decreases expression
ISO
Ritonavir results in decreased expression of CCND2 mRNA
CTD
PMID:16174765 PMID:19386116
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
G
Ccne2
cyclin E2
decreases expression
ISO
Ritonavir results in decreased expression of CCNE2 mRNA
CTD
PMID:19386116
NCBI chr 5:24,434,077...24,446,406
Ensembl chr 5:24,434,872...24,446,406
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Ritonavir results in decreased expression of CDK2 mRNA; Ritonavir results in decreased expression of CDK2 protein
CTD
PMID:16551874 PMID:19386116
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Ritonavir results in decreased expression of CDK4 mRNA; Ritonavir results in decreased expression of CDK4 protein
CTD
PMID:16551874 PMID:19386116
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
G
Cdk5
cyclin-dependent kinase 5
decreases expression
ISO
Ritonavir results in decreased expression of CDK5 mRNA
CTD
PMID:19386116
NCBI chr 4:7,282,945...7,287,427
Ensembl chr 4:7,282,948...7,288,383
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
Ritonavir results in decreased expression of CDK6 mRNA; Ritonavir results in decreased expression of CDK6 protein
CTD
PMID:16551874 PMID:19386116
NCBI chr 4:27,781,728...27,969,653
Ensembl chr 4:27,785,647...27,966,398
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
Ritonavir results in increased expression of CDKN1A mRNA; Ritonavir results in increased expression of CDKN1A protein manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased expression of CDKN1A protein]
CTD
PMID:19386116 PMID:20884875
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
Ritonavir results in increased expression of CDKN1B mRNA
CTD
PMID:19386116
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
increases expression
ISO
Ritonavir results in increased expression of CDKN2B mRNA
CTD
PMID:19386116
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
ISO
Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein]
CTD
PMID:11101056
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
G
Ciita
class II, major histocompatibility complex, transactivator
increases expression
ISO
Ritonavir results in increased expression of CIITA
CTD
PMID:26626330
NCBI chr10:5,212,621...5,260,641
Ensembl chr10:5,213,350...5,260,608
G
Crot
carnitine O-octanoyltransferase
decreases expression
EXP
Ritonavir results in decreased expression of CROT mRNA
CTD
PMID:17719200
NCBI chr 4:22,079,837...22,116,265
Ensembl chr 4:22,081,604...22,116,265
G
Cxcl1
C-X-C motif chemokine ligand 1
decreases expression
ISO
Ritonavir results in decreased expression of CXCL1
CTD
PMID:26626330
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
G
Cxcl10
C-X-C motif chemokine ligand 10
decreases expression
ISO
Ritonavir results in decreased expression of CXCL10
CTD
PMID:26626330
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
ISO
Ritonavir results in decreased expression of CXCL12
CTD
PMID:26626330
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
G
Cxcl2
C-X-C motif chemokine ligand 2
decreases expression
ISO
Ritonavir results in decreased expression of CXCL2
CTD
PMID:26626330
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
G
Cxcl3
C-X-C motif chemokine ligand 3
decreases expression
ISO
Ritonavir results in decreased expression of CXCL1
CTD
PMID:26626330
NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
G
Cxcl6
C-X-C motif chemokine ligand 6
decreases expression
ISO
Ritonavir results in decreased expression of CXCL6
CTD
PMID:26626330
NCBI chr14:18,860,201...18,920,839
Ensembl chr14:18,860,264...18,862,407
G
Cyb5r3
cytochrome b5 reductase 3
affects expression
EXP
Ritonavir affects the expression of CYB5R3 mRNA
CTD
PMID:17719200
NCBI chr 7:124,024,003...124,041,564
Ensembl chr 7:124,023,995...124,041,594
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
Ritonavir results in increased expression of CYP1A1 mRNA
CTD
PMID:11918509
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression decreases expression
ISO EXP
Ritonavir results in increased expression of CYP1A2 mRNA Ritonavir results in decreased expression of CYP1A2 mRNA
CTD
PMID:11918509 PMID:17719200
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases activity increases expression
ISO
Ritonavir results in increased activity of CYP2B6 protein Ritonavir results in increased expression of CYP2B6 protein
CTD
PMID:14977870 PMID:26626330
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
increases activity increases expression
ISO
Ritonavir results in increased activity of CYP2C9 protein Ritonavir results in increased expression of CYP2C9 mRNA
CTD
PMID:11918509 PMID:19202563
NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
G
Cyp2c6v1
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1
increases expression
ISO
Ritonavir results in increased expression of CYP2C19 mRNA
CTD
PMID:11918509
NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases activity
ISO
Ritonavir results in decreased activity of CYP2C8 protein
CTD
PMID:15601807
NCBI chr 1:147,236,480...147,307,988
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects metabolic processing
ISO
CYP2D6 protein affects the metabolism of Ritonavir
CTD
PMID:15286053
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
Ritonavir results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:17719200
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
affects binding increases expression affects metabolic processing decreases activity
ISO
CYP3A4 protein binds to Ritonavir analog Ritonavir results in increased expression of CYP3A4 mRNA CYP3A4 protein affects the metabolism of Ritonavir Ritonavir results in decreased activity of CYP3A4 protein
CTD
PMID:15286053 PMID:15523003 PMID:15860655 PMID:16837568 PMID:26626330 PMID:27966929
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases activity
ISO
Ritonavir results in decreased activity of CYP3A5 protein
CTD
PMID:15523003
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
decreases expression
EXP
Ritonavir results in decreased expression of CYP4A3 mRNA
CTD
PMID:17719200
NCBI chr 5:134,468,666...134,484,851
Ensembl chr 5:134,469,270...134,484,839
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
affects expression decreases expression
EXP
Ritonavir affects the expression of CYP4B1 mRNA Ritonavir results in decreased expression of CYP4B1 mRNA
CTD
PMID:17719200
NCBI chr 5:134,508,728...134,526,103
Ensembl chr 5:134,508,730...134,526,089
G
Cyp51
cytochrome P450, family 51
increases expression
EXP
Ritonavir results in increased expression of CYP51 mRNA
CTD
PMID:17719200
NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression
ISO EXP
Ritonavir results in decreased expression of CYP7A1 mRNA
CTD
PMID:17719200 PMID:26626330
NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
ISO EXP
Ritonavir results in decreased expression of CYP8B1 Ritonavir results in decreased expression of CYP8B1 mRNA
CTD
PMID:17719200 PMID:26626330
NCBI chr 8:130,548,418...130,550,388
Ensembl chr 8:130,548,418...130,550,388
G
Dhcr7
7-dehydrocholesterol reductase
affects expression
EXP
Ritonavir affects the expression of DHCR7 mRNA
CTD
PMID:17719200
NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
G
E2f1
E2F transcription factor 1
decreases expression
ISO
Ritonavir results in decreased expression of E2F1 mRNA; Ritonavir results in decreased expression of E2F1 protein
CTD
PMID:19386116
NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
G
E2f2
E2F transcription factor 2
decreases expression
ISO
Ritonavir results in decreased expression of E2F2 mRNA
CTD
PMID:19386116
NCBI chr 5:154,516,611...154,540,228
Ensembl chr 5:154,522,119...154,540,265
G
E2f3
E2F transcription factor 3
decreases expression
ISO
Ritonavir results in decreased expression of E2F3 mRNA
CTD
PMID:19386116
NCBI chr17:36,334,136...36,408,831
Ensembl chr17:36,334,147...36,408,831
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
affects expression
EXP
Ritonavir affects the expression of EHHADH mRNA
CTD
PMID:17719200
NCBI chr11:82,945,104...82,978,364
Ensembl chr11:82,945,104...82,978,364
G
Esr1
estrogen receptor 1
decreases expression
ISO
Ritonavir results in decreased expression of ESR1 protein
CTD
PMID:16551874
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Faslg
Fas ligand
decreases expression
ISO
Ritonavir results in decreased expression of FASLG protein
CTD
PMID:10551732
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
G
Fasn
fatty acid synthase
affects expression
EXP
Ritonavir affects the expression of FASN mRNA
CTD
PMID:17719200
NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
G
Fgf19
fibroblast growth factor 19
increases expression
ISO
Ritonavir results in increased expression of FGF19 mRNA
CTD
PMID:26626330
NCBI chr 1:218,058,405...218,061,693
Ensembl chr 1:218,058,405...218,061,693
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Ritonavir results in increased expression of FOS protein
CTD
PMID:15504750
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Glb1
galactosidase, beta 1
multiple interactions increases activity
ISO
Acetylcysteine inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; FTI 277 inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]
CTD
PMID:20884875
NCBI chr 8:122,439,328...122,511,939
Ensembl chr 8:122,439,328...122,511,939
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
multiple interactions
ISO
Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein]
CTD
PMID:11101056
NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Bilirubin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; HMOX1 protein inhibits the reaction [Ritonavir results in increased expression of ICAM1 protein]; NFE2L2 protein mutant form inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Ritonavir promotes the reaction [Atazanavir Sulfate results in increased expression of HMOX1 mRNA]; Ritonavir promotes the reaction [HMOX1 protein results in increased chemical synthesis of Bilirubin]; Ritonavir promotes the reaction [Lopinavir results in increased expression of HMOX1 mRNA]; Rotenone inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; tricarbonyldichlororuthenium (II) dimer promotes the reaction [Ritonavir results in increased expression of HMOX1 protein] Ritonavir results in increased expression of HMOX1 mRNA; Ritonavir results in increased expression of HMOX1 protein
CTD
PMID:15504750 PMID:26968795
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
affects response to substance
ISO
HSP90AA1 protein affects the susceptibility to Ritonavir
CTD
PMID:16551874
NCBI chr 6:135,107,262...135,112,793
Ensembl chr 6:135,107,271...135,112,775
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
Ritonavir results in increased expression of HSPH1 protein
CTD
PMID:26626330
NCBI chr12:6,322,685...6,341,898
Ensembl chr12:6,322,668...6,341,902
G
Icam1
intercellular adhesion molecule 1
increases expression multiple interactions
ISO
Ritonavir results in increased expression of ICAM1 protein HMOX1 protein inhibits the reaction [Ritonavir results in increased expression of ICAM1 protein]
CTD
PMID:26968795
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
G
Ifng
interferon gamma
multiple interactions
ISO
Ritonavir inhibits the reaction [IFNG protein results in increased secretion of TNF protein]
CTD
PMID:10551732
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Il6
interleukin 6
multiple interactions increases expression increases secretion
ISO
diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of IL6 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased secretion of IL6 protein]; Ritonavir inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] rosiglitazone inhibits the reaction [Ritonavir results in increased expression of IL6 mRNA] Ritonavir results in increased expression of IL6 mRNA; Ritonavir results in increased expression of IL6 protein
CTD
PMID:15388451 PMID:15865214 PMID:17668557 PMID:20884875
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Il7
interleukin 7
decreases expression
ISO
Ritonavir results in decreased expression of IL7
CTD
PMID:26626330
NCBI chr 2:96,427,884...96,474,979
Ensembl chr 2:96,439,286...96,474,977
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Ritonavir results in increased expression of JUN protein
CTD
PMID:15504750
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Lep
leptin
multiple interactions decreases expression
ISO
diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of LEP protein]
CTD
PMID:17668557
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
G
Lif
LIF, interleukin 6 family cytokine
decreases expression
ISO
Ritonavir results in decreased expression of LIF
CTD
PMID:26626330
NCBI chr14:84,482,652...84,500,574
Ensembl chr14:84,482,674...84,500,642
G
Lmna
lamin A/C
increases expression increases farnesylation
ISO
Ritonavir results in increased expression of LMNA protein Ritonavir results in increased farnesylation of LMNA protein alternative form
CTD
PMID:18230615 PMID:20884875
NCBI chr 2:187,842,884...187,863,552
Ensembl chr 2:187,842,885...187,863,516
G
Lpl
lipoprotein lipase
affects expression
ISO
Ritonavir affects the expression of LPL mRNA
CTD
PMID:11741158
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
Ritonavir results in decreased expression of MYC mRNA
CTD
PMID:16174765
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
G
Nfe2l2
nuclear factor, erythroid 2-like 2
increases expression multiple interactions
ISO
Ritonavir results in increased expression of NFE2L2 protein NFE2L2 protein mutant form inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]
CTD
PMID:26968795
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nfkb1
nuclear factor kappa B subunit 1
decreases activity
ISO
Ritonavir results in decreased activity of NFKB1 protein
CTD
PMID:16174765
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
G
Nfkbia
NFKB inhibitor alpha
decreases phosphorylation
ISO
Ritonavir results in decreased phosphorylation of NFKBIA protein
CTD
PMID:16174765
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nlrc5
NLR family, CARD domain containing 5
decreases expression
ISO
Ritonavir results in decreased expression of NLRC5
CTD
PMID:26626330
NCBI chr19:10,904,381...11,006,202
Ensembl chr19:10,905,542...10,976,396
G
Nos3
nitric oxide synthase 3
multiple interactions decreases expression
ISO
Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA]
CTD
PMID:22037733
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
G
Notch4
notch receptor 4
decreases expression multiple interactions
EXP
Ritonavir results in decreased expression of NOTCH4 protein [Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]
CTD
PMID:20722969
NCBI chr20:4,329,794...4,353,868
Ensembl chr20:4,329,811...4,353,785
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
increases expression
ISO
Ritonavir results in increased expression of NR1H4 mRNA
CTD
PMID:26626330
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions increases activity
ISO EXP
Ritonavir binds to and results in increased activity of NR1I2 protein Ritonavir results in increased activity of NR1I2 protein
CTD
PMID:14977870 PMID:15849716 PMID:27732639
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
Ritonavir results in increased cleavage of PARP1 protein
CTD
PMID:19386116 PMID:21270666
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Pon1
paraoxonase 1
decreases activity
EXP
Ritonavir results in decreased activity of PON1 protein
CTD
PMID:27378623
NCBI chr 4:30,249,749...30,276,297
Ensembl chr 4:30,249,742...30,276,372
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
ISO
Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein] Ritonavir results in increased expression of PPARG mRNA
CTD
PMID:11101056 PMID:17879945
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
G
Prkca
protein kinase C, alpha
multiple interactions increases activity increases expression
ISO
Ritonavir binds to and affects the localization of PRKCA protein Ritonavir results in increased activity of PRKCA protein Ritonavir results in increased expression of PRKCA protein
CTD
PMID:22020176
NCBI chr10:96,186,509...96,585,168
Ensembl chr10:96,191,133...96,584,947
G
Psma1
proteasome 20S subunit alpha 1
affects expression
EXP
Ritonavir affects the expression of PSMA1 mRNA
CTD
PMID:17719200
NCBI chr 1:183,733,567...183,744,586
Ensembl chr 1:183,733,567...183,744,586
G
Psmb3
proteasome 20S subunit beta 3
affects expression
EXP
Ritonavir affects the expression of PSMB3 mRNA
CTD
PMID:17719200
NCBI chr10:85,646,646...85,653,729
Ensembl chr10:85,646,633...85,653,729
G
Psmb5
proteasome 20S subunit beta 5
increases expression
EXP
Ritonavir results in increased expression of PSMB5 mRNA
CTD
PMID:20213465
NCBI chr15:33,259,039...33,263,634
Ensembl chr15:33,259,043...33,263,659
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation increases expression
ISO
Ritonavir results in decreased phosphorylation of RB1 protein Ritonavir results in increased expression of RB1 mRNA
CTD
PMID:16551874 PMID:19386116 PMID:21270666
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
G
Rbl1
RB transcriptional corepressor like 1
increases expression
ISO
Ritonavir results in increased expression of RBL1 mRNA
CTD
PMID:19386116
NCBI chr 3:153,263,692...153,321,351
Ensembl chr 3:153,263,692...153,321,352
G
Rbl2
RB transcriptional corepressor like 2
decreases expression
ISO
Ritonavir results in decreased expression of RBL2 mRNA
CTD
PMID:19386116
NCBI chr19:17,300,088...17,346,865
Ensembl chr19:17,300,089...17,346,808
G
Rel
REL proto-oncogene, NF-kB subunit
decreases activity
ISO
Ritonavir results in decreased activity of REL protein
CTD
PMID:16174765
NCBI chr14:108,490,794...108,517,582
Ensembl chr14:108,491,069...108,509,892
G
Rela
RELA proto-oncogene, NF-kB subunit
decreases activity
ISO
Ritonavir results in decreased activity of RELA protein
CTD
PMID:16174765
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Scarb1
scavenger receptor class B, member 1
multiple interactions increases expression
ISO
Estradiol inhibits the reaction [Ritonavir results in increased expression of SCARB1 protein] Ritonavir results in increased expression of SCARB1 mRNA
CTD
PMID:17879945
NCBI chr12:36,694,952...36,761,445
Ensembl chr12:36,694,960...36,761,455
G
Scp2
sterol carrier protein 2
decreases expression
ISO
Ritonavir results in decreased expression of SCP2
CTD
PMID:26626330
NCBI chr 5:127,647,934...127,735,703
Ensembl chr 5:127,620,274...127,735,739
G
Slc10a1
solute carrier family 10 member 1
decreases expression
ISO
Ritonavir results in decreased expression of SLC10A1
CTD
PMID:26626330
NCBI chr 6:104,617,730...104,631,355
Ensembl chr 6:104,617,730...104,631,355
G
Slc51a
solute carrier family 51 subunit alpha
decreases expression
ISO
Ritonavir results in decreased expression of SLC51A
CTD
PMID:26626330
NCBI chr11:71,533,078...71,547,476
Ensembl chr11:71,533,078...71,547,476
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
decreases phosphorylation
ISO
Ritonavir results in decreased phosphorylation of SRC protein
CTD
PMID:21270666
NCBI chr 3:153,547,807...153,595,643
Ensembl chr 3:153,580,861...153,595,642
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SREBF1 protein]
CTD
PMID:11101056
NCBI chr10:46,570,996...46,593,021
Ensembl chr10:46,570,996...46,593,009
G
Stat3
signal transducer and activator of transcription 3
decreases phosphorylation
ISO
Ritonavir results in decreased phosphorylation of STAT3 protein
CTD
PMID:21270666
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Tjp1
tight junction protein 1
decreases expression multiple interactions
EXP
Ritonavir results in decreased expression of TJP1 protein [Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]
CTD
PMID:20722969
NCBI chr 1:126,146,489...126,515,359
Ensembl chr 1:126,146,489...126,227,469
G
Tnf
tumor necrosis factor
decreases secretion multiple interactions increases expression
ISO
Ritonavir results in decreased secretion of TNF protein rosiglitazone inhibits the reaction [Ritonavir results in increased expression of TNF mRNA] Ritonavir inhibits the reaction [IFNG protein results in increased secretion of TNF protein]; Ritonavir inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Ritonavir results in increased expression of TNF mRNA; Ritonavir results in increased expression of TNF protein
CTD
PMID:10551732 PMID:15388451 PMID:15865214
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO
FTI 277 inhibits the reaction [Ritonavir results in increased expression of TP53 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased expression of TP53 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased expression of TP53 protein]
CTD
PMID:19386116 PMID:20884875
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
affects expression
ISO
Ritonavir affects the expression of UGT1A1 mRNA
CTD
PMID:15849716
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Zmpste24
zinc metallopeptidase STE24
decreases activity
ISO
Ritonavir results in decreased activity of ZMPSTE24 protein
CTD
PMID:18230615
NCBI chr 5:139,982,404...140,015,541
Ensembl chr 5:139,983,680...140,015,541
G
Egf
epidermal growth factor
multiple interactions
EXP
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Valine; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Valine]
CTD
PMID:22689575
NCBI chr 2:68,820,616...68,895,537
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all